Guru Ownership Trend
Guru Analysis for Capricor Therapeutics, Inc. (CAPR)
Capricor Therapeutics, Inc. (CAPR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.57 M.
Top institutional holders include Steven Cohen and Jefferies Group.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $27.75 M net outflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position. Conversely, Steven Cohen reduced exposure by 55.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Capricor Therapeutics, Inc. (CAPR)
Major holders include Steven Cohen ($24.96 M), Jefferies Group ($3.17 M), Cliff Asness ($304,669). According to the latest reported data, 3 tracked investment managers collectively hold approximately 935,562 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $27.75 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CAPR. The total reported sell value was $30.97 M.
Yes, 1 managers opened new positions in CAPR, and 1 increased their existing holdings. The total reported buy value was $3.22 M.